ASTRO: HRQOL Superior With SBRT for Intermediate-Risk Localized Prostate Cancer
Favorable bowel HRQOL seen with stereotactic body radiation therapy compared with intensity-modulated radiation therapy; no difference seen in disease-free survival
Adherence to ACS Guideline Linked to Lower Mortality in Nonmetastatic Prostate Cancer
Lower mortality risk seen for those who improved guideline concordance after diagnosis or maintained high concordance
Acute Cystitis Tied to Higher Risk for Urogenital Cancers
Risks especially high within three months of infection
Wrist Cooling May Help Manage Vasomotor Symptoms
Benefits seen across participants with breast or prostate cancer, as well as postmenopausal women
Remote Access to Urinary Incontinence Treatments Aids Women Veterans
Findings seen for either a mobile health app or video visit
Surgical Volume Increases With Introduction of HoLEP
Surgical volume increased significantly after adoption of holmium laser enucleation of the prostate, with no change in catchment area
Magnesium Depletion Linked to Increased Overactive Bladder Risk
Association was particularly pronounced in women, nonsmokers, middle-aged adults, and those with obesity
Biparametric MRI Noninferior for Diagnosing Prostate Cancer
Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI
FDA Approves Inlexzo for Bladder Cancer
First and only drug releasing system is indicated for patients with BCG-unresponsive non-muscle-invasive bladder cancer seeking bladder preservation
Childhood GI Disorders May Be Predictive for Interstitial Cystitis
Gastrointestinal conditions and urological anomalies significantly increase the risk for developing IC in adulthood
